1. Adelaide Research & Scholarship

Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-8 of 8 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinomaAl-Ejeh, F.; Pajic, M.; Shi, W.; Kalimutho, M.; Miranda, M.; Nagrial, A.; Chou, A.; Biankin, A.; Grimmond, S.; Brown, M.; Khanna, K.
2015Progesterone receptor modulates ERα action in breast cancerMohammed, H.; Russell, I.; Stark, R.; Rueda, O.; Hickey, T.; Tarulli, G.; Serandour, A.; Birrell, S.; Bruna, A.; Saadi, A.; Menon, S.; Hadfield, J.; Pugh, M.; Raj, G.; Brown, G.; D'Santos, C.; Robinson, J.; Silva, G.; Launchbury, R.; Perou, C.; et al.
2015Systematic screening identifies dual PI3K and mTOR Inhibition as a conserved therapeutic vulnerability in osteosarcomaGupte, A.; Baker, E.; Wan, S.; Stewart, E.; Loh, A.; Shelat, A.; Gould, C.; Chalk, A.; Taylor, S.; Lackovic, K.; Karlström, Å.; Mutsaers, A.; Desai, J.; Madhamshettiwar, P.; Zannettino, A.; Burns, C.; Huang, D.; Dyer, M.; Simpson, K.; Walkley, C.
2014Discovery of (E)-3-((Styrylsulfonyl) methyl) pyridine and (E)-2-((Styrylsulfonyl) methyl) pyridine Derivatives as Anticancer Agents: Synthesis, Structure–Activity Relationships, and Biological ActivitiesLu, T.; Goh, A.W.; Yu, M.; Adams, J.; Lam, F.; Teo, T.; Li, P.; Noll, B.; Zhong, L.; Diab, S.; Chahrour, O.; Hu, A.; Abbas, A.; Liu, X.; Huang, S.; Sumby, C.; Milne, R.; Midgley, C.; Wang, S.
2013Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancerRavindranathan, P.; Lee, T.; Yang, L.; Centenera, M.; Butler, L.; Tilley, W.; Hsieh, J.; Ahn, J.; Raj, G.
2010BNC105: a novel tubulin polymerization inhibitor that selectively disrupts tumor vasculature and displays single-agent antitumor efficacyKremmidiotis, G.; Leske, A.; Lavranos, T.; Beaumont, D.; Gasic, J.; Hall, A.; O’Callaghan, M.; Matthews, C.; Flynn, B.
2015Cabozantinib inhibits abiraterone's upregulation of IGFIR phosphorylation and enhances its anti-prostate cancer activityWang, X.; Huang, Y.; Christie, A.; Bowden, M.; Lee, G.; Kantoff, P.; Sweeney, C.
2017CIB2 negatively regulates oncogenic signaling in ovarian cancer via sphingosine kinase 1Zhu, W.; Jarman, K.; Lokman, N.; Neubauer, H.; Davies, L.; Gliddon, B.; Taing, H.; Moretti, P.; Oehler, M.; Pitman, M.; Pitson, S.

Discover